Tumor necrosis factor-α-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis

Clinical Cancer Research

Volumn 7, Issue 11 SUPPL., 2001, Pages

  Esche, Clemens ^a   Shurin, Galina V ^a   Kirkwood, John M ^a   Wang, Gui Qiang ^a   Rabinowich, Hannah ^a   Pirtskhalaishvili, Georgi ^a   Shurin, Michael R ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b CLSI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2L1 PROTEIN, MOUSE; CYTOCHROME C; DNA FRAGMENT; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DENDRITIC CELL; DRUG ANTAGONISM; EXPERIMENTAL MELANOMA; GENETIC TRANSFECTION; MALE; MELANOMA; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CYTOCHROME C GROUP; DENDRITIC CELLS; DNA FRAGMENTATION; MALE; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035289454     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. Immunobiology of dendritic cells. Annu. Rev. Immunol., 18: 767-811, 2000.
2. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med., 179: 1109-1118, 1994.
3. Esche, C., Shurin, M. R., and Lotze, M. T. The use of dendritic cells for cancer vaccination. Curr. Opin. Mol. Ther., 1: 72-81, 1999.
4. Wojtowicz-Praga, S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy [see comments]. J. Immunother., 20: 165-177, 1997.
5. Kavanaugh, D. Y., and Carbone, D. P. Immunologic dysfunction in cancer. Hematol. Oncol. Clin. North Am., 10: 927-951, 1996.
6. Shurin, M. R., Kirkwood, J. M., and Esche, C. Cytokine-based therapy for melanoma: pre-clinical studies. FORUM Trends Exp. Clin. Med., 10: 205-227, 2000.
7. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J., and Tschopp, J. Melanoma cell expression of Fas(Apo-1/ CD95) ligand: implications for tumor immune escape [see comments]. Science (Washington DC), 274: 1363-1366, 1996.
8. Fraser, A., and Evan, G. A license to kill. Cell, 85: 781-784, 1996.
9. Chappell, D. B., Zaks, T. Z., Rosenberg, S. A., and Restifo, N. P. Human melanoma cells do not express Fas (Apo-1/CD95) ligand. Cancer Res., 59: 59-62, 1999.
10. Terheyden, P., Siedel, C., Merkel, A., Kumpgen, E., Brocker, E. B., and Becker, J. C. Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis. J. Invest. Dermatol., 112: 899-902, 1999.
11. Shurin, M. R., and Gabrilovich, D. I. Regulation of dendritic cell system by tumor. Cancer Res. Ther. Control, in press, 2001.
12. Esche, C., Lokshin, A., Shurin, G. V., Gastman, B. R., Rabinowich, H., Watkins, S. C., Lotze, M. T., and Shurin, M. R. Tumor's other immune targets: dendritic cells. J. Leukocyte Biol., 66: 336-344, 1999.
13. Shurin, M. R., Esche, C., Lokshin, A., and Lotze, M. T. Apoptosis in dendritic cells. In: M. T. Lotze and A. W. Thomson (eds.), Dendritic Cells: Biology and Clinical Applications, pp. 673-692. San Diego: Academic Press, 1999.
14. Esche, C., Gambotto, A., Satoh, Y., Gerein, V., Robbins, P. D., Watkins, S. C., Lotze, M. T., and Shurin, M. R. CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth. Eur. J. Immunol., 29: 2148-2155, 1999.
15. Pirtskhalaishvili, G., Shurin, G. V., Esche, C., Cai, Q., Salup, R. R., Bykovskaia, S. N., Lotze, M. T., and Shurin, M. R. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br. J. Cancer, 83: 506-513, 2000.
16. Kiertscher, S. M., Luo, J., Dubinett, S. M., and Roth, M. D. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol., 164: 1269-1276, 2000.
17. Almand, B., Resser, J. R., Lindman, B., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., and Gabrilovich, D. I. Clinical significance of defective dendritic cell differentiation in cancer. Clin. Cancer Res., 6: 1755-1766, 2000.
18. L increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J. Immunol., 165: 1956-1964, 2000.
19. Matzinger, P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods, 145: 185-192, 1991.
20. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked [see comments]. Science (Washington DC), 275: 1129-1132, 1997.
21. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis [see comments]. Science (Washington DC), 275: 1132-1136, 1997.
22. Kerr, J. F., Wyllie, A. H., and Currie. A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
23. Salvesen, G. S., and Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell, 91: 443-446, 1997.
24. Xiang, J., Chao, D. T., and Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93: 14559-14563, 1996.
25. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
26. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86: 147-157, 1996.
27. Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., and Green, D. R. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant [see comments], Nat. Cell Biol., 2: 156-162, 2000.
28. Kim, C. N., Wang, X., Huang, Y., Ibrado, A. M., Liu, L., Fang, G., and Bhalla, K. Overexpression of Bcl-X(L) inhibits ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res., 57: 3115-3120, 1997.
29. Rosse, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., and Borner, C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c [see comments]. Nature (Lond.), 391: 496-499, 1998.
30. Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., Mutsuda, H., and Tsujimoto, Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95: 14681-14686, 1998.
31. Akao, Y., Otsuki, Y., Kataoka, S., Ito, Y., and Tsujimoto, Y. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res., 54: 2468-2471, 1994.
32. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997.
33. Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T., and Tohyama, M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J. Biol. Chem., 274: 8531-8538, 1999.
34. Becker, Y. Anticancer role of dendritic cells (DC) in human and experimental cancers-a review. Anticancer Res., 12: 511-520, 1992.
35. Tsujimoto, Y., and Shimizu, S. Bcl-2 family: life-or-death switch. FEBS Lett., 466: 6-10, 2000.
36. Cleary, M. L., Smith, S. D., and Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19-28, 1986.
37. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
38. Vaax, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
39. Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C., and Raff, M. C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.), 361: 365-369, 1993.